| Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues S Zanganeh, G Hutter, R Spitler, O Lenkov, M Mahmoudi, A Shaw, ... Nature nanotechnology 11 (11), 986-994, 2016 | 1517 | 2016 |
| Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET HE Daldrup-Link, C Franzius, TM Link, D Laukamp, J Sciuk, H Jürgens, ... American Journal of Roentgenology 177 (1), 229-236, 2001 | 596 | 2001 |
| Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label … NM Marina, S Smeland, SS Bielack, M Bernstein, G Jovic, MD Krailo, ... The Lancet Oncology 17 (10), 1396-1408, 2016 | 533 | 2016 |
| Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance W Wu, JL Klockow, M Zhang, F Lafortune, E Chang, L Jin, Y Wu, ... Pharmacological research 171, 105780, 2021 | 424 | 2021 |
| Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. P Reimer, EJ Rummeny, K Shamsi, T Balzer, HE Daldrup, B Tombach, ... Radiology 199 (1), 177-183, 1996 | 374 | 1996 |
| FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy C Franzius, J Sciuk, HE Daldrup-Link, H Jürgens, O Schober European journal of nuclear medicine 27, 1305-1311, 2000 | 359 | 2000 |
| MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles HE Daldrup-Link, D Golovko, B Ruffell, DG DeNardo, R Castaneda, ... Clinical Cancer Research 17 (17), 5695-5704, 2011 | 345 | 2011 |
| Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. H Daldrup, DM Shames, M Wendland, Y Okuhata, TM Link, W Rosenau, ... AJR. American journal of roentgenology 171 (4), 941-949, 1998 | 330 | 1998 |
| Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro S Metz, G Bonaterra, M Rudelius, M Settles, EJ Rummeny, ... European radiology 14, 1851-1858, 2004 | 320 | 2004 |
| Targeting of hematopoietic progenitor cells with MR contrast agents HE Daldrup-Link, M Rudelius, RAJ Oostendorp, M Settles, G Piontek, ... Radiology 228 (3), 760-767, 2003 | 320 | 2003 |
| Current and potential imaging applications of ferumoxytol for magnetic resonance imaging GB Toth, CG Varallyay, A Horvath, MR Bashir, PL Choyke, ... Kidney international 92 (1), 47-66, 2017 | 306 | 2017 |
| Migration of iron oxide–labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment HE Daldrup-Link, M Rudelius, G Piontek, S Metz, R Bräuer, G Debus, ... Radiology 234 (1), 197-205, 2005 | 260 | 2005 |
| FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT C Franzius, HE Daldrup-Link, J Sciuk, EJ Rummeny, S Bielack, H Jürgens, ... Annals of Oncology 12 (4), 479-486, 2001 | 257 | 2001 |
| Fiber management drawer and sliding cable slack limiter M Kim, MJ Wentworth, TD Smith US Patent 6,748,155, 2004 | 240 | 2004 |
| Clinical results with Resovist: a phase 2 clinical trial. P Reimer, EJ Rummeny, HE Daldrup, T Balzer, B Tombach, T Berns, ... Radiology 195 (2), 489-496, 1995 | 240 | 1995 |
| Cell tracking with optical imaging EJ Sutton, TD Henning, BJ Pichler, C Bremer, HE Daldrup-Link European radiology 18, 2021-2032, 2008 | 225 | 2008 |
| Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging—a multicenter phase III clinical study J Petersein, A Spinazzi, A Giovagnoni, P Soyer, F Terrier, R Lencioni, ... Radiology 215 (3), 727-736, 2000 | 221 | 2000 |
| Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging P Reimer, EJ Rummeny, HE Daldrup, T Hesse, T Balzer, B Tombach, ... European radiology 7, 275-280, 1997 | 209 | 1997 |
| In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging HE Daldrup-Link, R Meier, M Rudelius, G Piontek, M Piert, S Metz, ... European radiology 15, 4-13, 2005 | 204 | 2005 |
| T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5 T and 3T clinical MR scanning GH Simon, J Bauer, O Saborovski, Y Fu, C Corot, MF Wendland, ... European radiology 16, 738-745, 2006 | 196 | 2006 |
Ernst J. RUMMENYProfessor of RadiologyVerified email at tum.de
